Welcome to our dedicated page for Phreesia SEC filings (Ticker: PHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Phreesia filings document the company’s operating results, material agreements, capital structure and governance as a public healthcare technology company. Recent Form 8-K disclosures include quarterly financial results, stakeholder letters and earnings-call materials, along with material definitive agreements connected to credit facilities, acquisition financing and receivables arrangements.
The filing record also documents the completed AccessOne acquisition, the use and refinancing of related debt, and subsidiary arrangements involving AccessOne Funding and AccessOne MedCard. Governance disclosures include board composition changes, director compensation matters and shareholder-voting subjects, while capital-structure disclosures cover secured revolving credit, bridge-loan obligations and receivables purchase agreements.
Phreesia, Inc. provides an integrated software, payments and patient-engagement platform that supports access, affordability and outcomes across the U.S. healthcare system. In fiscal 2026, its platform supported about 180 million patient visits, roughly one in six ambulatory visits in the United States.
The company reports a diversified revenue model from subscription and related services, payment solutions and Network Solutions, and estimates a $24 billion total addressable market across these lines. Phreesia completed the AccessOne acquisition to expand healthcare payment and financing capabilities, operates fully remotely with 1,789 employees, and highlights extensive regulatory, cybersecurity, competition, AI, financing and privacy risks that could materially affect future results.
Phreesia reported a strong turnaround for fiscal 2026, achieving profitability and robust cash generation. Fiscal-year revenue reached $480.6 million, up 14% year-over-year. Net income was $2.3 million, compared with a $58.5 million loss in fiscal 2025, while Adjusted EBITDA rose to $101.5 million from $36.8 million.
Free cash flow improved to $54.4 million from $8.3 million, supported by operating cash flow of $78.8 million. In the fourth quarter, revenue was $127.1 million, up 16%, with net income of $1.3 million and Adjusted EBITDA of $29.4 million. The company closed the $164 million AccessOne Acquisition and later refinanced its $110 million Bridge Loan into a new $275 million, five-year senior secured revolving credit facility.
For fiscal 2027, Phreesia lowered its revenue outlook to $510–$520 million from $545–$559 million, citing lower second-half commitments from certain pharmaceutical network solutions clients, but maintained its Adjusted EBITDA target of $125–$135 million. Management expects continued operating leverage, aided by AI-driven efficiency initiatives, and mid-single-digit AHSC growth with lower revenue-per-client growth.
Phreesia, Inc.’s Chief Financial Officer Balaji Gandhi reported a small, tax-related share sale. On the reported date, he disposed of 3,829 shares of common stock at a weighted average price of $11.2635 per share. A footnote explains these were non-discretionary transactions under the company’s mandatory sell-to-cover policy to satisfy tax withholding on settling restricted stock units, rather than elective open‑market sales. After this activity, he directly held 146,740 shares.
Phreesia Inc ownership update: The Vanguard Group filed an Amendment No. 4 to Schedule 13G/A stating it beneficially owns 0 shares of Phreesia Inc common stock, representing 0% of the class. The filing explains an internal realignment on January 12, 2026 that led certain Vanguard subsidiaries to report holdings separately.
Phreesia, Inc. General Counsel & Secretary Allison C. Hoffman reported an open-market sale of 6,176 shares of Phreesia common stock at $11.97 per share on March 23, 2026. After this transaction, she directly holds 163,485 shares of Phreesia common stock. The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on December 19, 2025, indicating the trade was scheduled in advance rather than timed discretionarily.
PHR filed a Form 144 reporting a proposed sale of Common shares tied to a restricted stock vesting. The filing lists 3,829 shares with an effective/offer date of 03/24/2026 and indicates the broker Fidelity Brokerage Services LLC for transactions on 03/25/2026.
The filing also discloses prior sales by Balaji Gandhi in the past three months: 8,009, 975, and 4,687 shares on 01/08/2026, 01/15/2026, and 01/16/2026, respectively.
Allison C. Hoffman filed a Form 144 reporting proposed sales of Common Stock.
The filing lists three dispositions: 6,585 shares on 01/08/2026 for $111,991.75; 1,106 shares on 01/15/2026 for $18,115.73; and 3,995 shares on 01/16/2026 for $65,345.42.
The filing also lists securities tied to prior compensation events and vesting dates, including restricted stock vesting and ESPP purchases with quantities of 137, 298, 3,643, 1,109, and 989 on the dates shown in the excerpt.
Phreesia, Inc. reported a series of open-market insider purchases by an affiliated investment vehicle. Over three days, Pale Fire Capital SICAV a.s., part of a group that may be deemed to own more than 10% of Phreesia, bought a total of 1,602,505 shares of common stock in the open market. The purchases included 303,300 shares at a price of $11.1962 on one day, 519,196 shares at $11.1531 on the next, and 780,009 shares at $11.6899 on the following day. After these transactions, Pale Fire Capital SICAV a.s. indirectly held 7,648,829 shares of Phreesia common stock. The filing notes that the reporting persons disclaim beneficial ownership beyond their pecuniary interest and that prices reflect weighted averages for multiple trades within narrow price ranges.
Pale Fire Capital–affiliated entities have filed an initial ownership report on Phreesia, Inc. The filing shows that Pale Fire Capital SICAV a.s. indirectly holds 6,046,324 shares of Phreesia common stock. Together with related entities and individuals, they may be part of a Section 13(d) group owning more than 10% of Phreesia’s outstanding shares.
The structure concentrates ownership at the fund level, with Pale Fire Capital SE and its investment manager and principals potentially deemed beneficial owners through control relationships. All reporting persons disclaim beneficial ownership beyond their economic interest in these securities.
Pale Fire Capital and associated entities filed an amended Schedule 13D reporting a substantial ownership position in Phreesia, Inc. The group reports beneficial ownership of 7,648,829 shares of common stock, representing approximately 12.7% of Phreesia’s outstanding shares based on 60,287,003 shares outstanding as of December 2, 2025.
The filing states that Pale Fire Capital SICAV a.s. acquired these shares using working capital, with an aggregate purchase price of about $93,009,793 including brokerage commissions. Related Czech entities and individuals, including Pale Fire Capital investicni spolecnost a.s., Pale Fire Capital, Dusan Senkypl, and Jan Barta, may be deemed beneficial owners through their control roles, while expressly disclaiming beneficial ownership of shares they do not directly own. Recent transactions are referenced in an exhibit listing open‑market trades.